Caribou Biosciences Inc.
CRBU | NASDAQ
$1.30
$0 (0.00%)
At close: Sep 21, 2026, 4:00 PM ET
$1.30
$0 (0.00%)
Pre-market:
Sep 22, 2026, 4:00 AM ET
Market Data
Market Cap $128.93M
Enterprise Value $43.28M
Beta 2.28
Average Volume 1.7M
Shares Outstanding (Diluted) 100.99M
Shares Change YoY 8.55%
Institutional Ownership 39.48%
Exchange NASDAQ
ISIN US1420381089
Price Performance
Price Change 1M -22.2%
Price Change 3M -21.7%
Price Change 6M -30.9%
Price Change YTD -18.2%
Price Change 1Y -32.6%
Price Change 3Y -74.5%
Price Change 5Y -94.6%
1M CAGR (ann.) -21.2%
1Y CAGR (ann.) -27.0%
5Y CAGR (ann.) -45.7%
All-Time CAGR -38.7%
Valuation
PE Ratio -1.20
Forward PE N/A
PEG Ratio -0.02
Forward PEG -0.04
PS Ratio 15.10
Forward PS 10.50
PB Ratio 1.31
P/FCF Ratio -1.35
P/Adj. FCF Ratio -1.21
P/OCF Ratio -1.37
EV/Sales 5.07
EV/EBIT -0.54
EV/EBITDA -0.42
EV/FCF -0.45
Earnings Yield -83.1%
FCF Yield -74.3%
Adj. FCF Yield -82.4%
Financial Health
Net Cash $85.66M
Total Debt $26.66M
Cash & Short-Term Investments $112.31M
Total Assets $142.77M
Current Ratio 6.49
Quick Ratio 6.49
Debt / Equity Ratio 0.27
Debt / EBITDA -0.26
Debt / FCF -0.28
OCF / Debt -3.59
Interest Coverage 0.00
Altman Z-Score -5.55
Piotroski F-Score 4
Margins & Profitability
Gross Profit Margin -129.7%
Operating Profit Margin -1282.5%
EBITDA Margin -1037.4%
Net Profit Margin -1030.4%
FCF Margin -1121.7%
Adj. FCF Margin -1244.8%
SBC / Revenue 104.7%
SBC Impact (per share) -11.0%
Returns
Return on Assets -72.4%
Return on Equity -89.1%
Return on Invested Capital -86.3%
Return on Capital Employed -87.7%
Return on Tangible Assets -72.4%
Historical Growth (CAGR)
Revenue CAGR 3Y -15.7%
Revenue CAGR 5Y 10.2%
Revenue CAGR 10Y N/A
EPS CAGR 3Y 10.9%
EPS CAGR 5Y 6.2%
EPS CAGR 10Y N/A
FCF CAGR 3Y 15.2%
FCF CAGR 5Y -5.4%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 9
EPS Growth Next 3Y -51.5%
Revenue Growth Next 3Y 24.6%
Earnings Date Nov 10, 2026
EPS Estimate (next Q) -$0.29
EPS Growth Est (next Q) -3.3%
Revenue Est (next Q) $2.18M
Revenue Growth Est (next Q) -0.8%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $5
Price Target Upside 284.6%
Cash Flow
Operating Cash Flow $-95.78M
Free Cash Flow $-95.75M
Adj. Free Cash Flow $-106.26M
FCF Per Share -$0.95
OCF Per Share -$0.95
OCF/S Ratio -954.5%
Income Statement
Revenue $8.54M
Gross Profit $-14.51M
Operating Income $-109.47M
EBITDA $-103.05M
Net Income $-103.4M
EPS (Diluted) -$1.08
Revenue / Employee $88K
Profit / Employee $-1.07M
Employees 97
Add to Watchlist
Select watchlists to add or remove CRBU